November 05, 2025

Get In Touch

Cementless Total Knee Arthroplasty Safe For Osteoporotic Patients Under 75, Unravels Study

Researchers found that patients with osteoporosis younger than 75 years of age who underwent cementless total knee arthroplasty (TKA) had comparable results of implant-related complications, medical complications, readmissions, and implant survival as those undergoing cemented TKA. A recent study was published in The Journal of Arthroplasty. The study was conducted by Jacquelyn and colleagues
Historical contraindications for TKA have included poor bone stock, a characteristic common to osteoporotic individuals. This study seeks to establish whether patients with osteoporosis who are below 75 years old and undergo cementless TKA have comparable implant-related and medical complications, hospital readmission rates, and 3-year implant survivability to those who undergo the cemented technique.
Using a national administrative claims database from 2010 to 2022, this study conducted a retrospective analysis of data. The inclusion criteria were patients 75 or younger with osteoporosis at diagnosis who received primary TKA. The cohort was split into two treatment groups according to the presence of cementless versus cemented TKA. To allow for a balanced comparison, propensity score matching was applied controlling for age, sex, obesity, and the Charleston Comorbidity Index (CCI), creating two well-matched groups: 1,321 patients in the cementless group and 6,602 in the cemented group. Primary endpoints consisted of the 90-day and 2-year implant-related complications, and the postoperative medical complications at 90 days and readmissions at 90 days. Additionally, Kaplan-Meier survival analysis was performed to assess the all-cause revision implant survivability rate at 3 years. The level of significance for type 1 error was set at P < 0.01 to minimize the error of the first type.
Key Findings
No statistically significant complications were detected between the cementless group and the cemented TKA regarding implant-related complications, medical complications, and admission rates within 90 days after the research.
The main results included the following.
• Implant-related complications: No significant difference between cemented and cementless groups.
• Medical complications within 90 days: Similar rates between both cohorts.
• 90-day readmissions: No statistically significant differences.
• Lengths of hospital stay were also comparable between the two groups.
The Kaplan-Meier analysis demonstrated that the 3-year implant survivability was nearly identical between the cemented and cementless TKA groups:
• Cemented TKA survivability: 97.6% (95% confidence interval [CI], 96.6 to 98.5),
• Cementless TKA survivability: 97.2% (95% CI, 96.7 to 97.7),
This study had strong evidence that when it comes to cementless TKA in osteoporotic patients under 75 years old, complications rates and implant survivability weren't significantly different compared with patients treated with cemented TKA. Surgeons might extend the indications of cementless TKA to a broader spectrum than standard and report the results in osteoporotic patients, accounting for variability in individual bone strength.
Reference:
Xu, J. J., Magruder, M. L., Lama, G., Vakharia, R., Tabbaa, A., & Wong, J. (2024). Osteoporosis may not be an absolute contraindication for cementless total knee arthroplasty. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2024.10.011

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!